CN1089585C - 左布比卡因在面部手术中的用途 - Google Patents

左布比卡因在面部手术中的用途 Download PDF

Info

Publication number
CN1089585C
CN1089585C CN98802994A CN98802994A CN1089585C CN 1089585 C CN1089585 C CN 1089585C CN 98802994 A CN98802994 A CN 98802994A CN 98802994 A CN98802994 A CN 98802994A CN 1089585 C CN1089585 C CN 1089585C
Authority
CN
China
Prior art keywords
levobupivacaine
surgery
administered
bupivacaine
block
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN98802994A
Other languages
English (en)
Chinese (zh)
Other versions
CN1249684A (zh
Inventor
B·A·金纳利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of CN1249684A publication Critical patent/CN1249684A/zh
Application granted granted Critical
Publication of CN1089585C publication Critical patent/CN1089585C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CN98802994A 1997-03-03 1998-03-03 左布比卡因在面部手术中的用途 Expired - Lifetime CN1089585C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9704352.5A GB9704352D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use
GB9704352.5 1997-03-03

Publications (2)

Publication Number Publication Date
CN1249684A CN1249684A (zh) 2000-04-05
CN1089585C true CN1089585C (zh) 2002-08-28

Family

ID=10808603

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98802994A Expired - Lifetime CN1089585C (zh) 1997-03-03 1998-03-03 左布比卡因在面部手术中的用途

Country Status (20)

Country Link
US (1) US5919804A (https=)
EP (1) EP0981347B1 (https=)
JP (1) JP2001513812A (https=)
KR (1) KR100516676B1 (https=)
CN (1) CN1089585C (https=)
AT (1) ATE240730T1 (https=)
AU (1) AU730390B2 (https=)
BR (1) BR9808303A (https=)
CA (1) CA2279497C (https=)
DE (1) DE69814851T2 (https=)
DK (1) DK0981347T3 (https=)
ES (1) ES2199423T3 (https=)
GB (1) GB9704352D0 (https=)
HU (1) HU225151B1 (https=)
IL (1) IL131084A0 (https=)
NO (1) NO322446B1 (https=)
PL (1) PL190900B1 (https=)
PT (1) PT981347E (https=)
WO (1) WO1998038996A1 (https=)
ZA (1) ZA981779B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998286A2 (en) * 1997-07-21 2000-05-10 Darwin Discovery Limited Use of levobupivacaine
AU739510B2 (en) * 1997-07-22 2001-10-11 Darwin Discovery Limited Levobupivacaine and its use
EP1030652B1 (en) 1997-11-14 2012-04-25 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
AU752225B2 (en) 1998-07-17 2002-09-12 Pacira Pharmaceuticals, Inc. Biodegradable compositions for the controlled release of encapsulated substances
US20030096000A1 (en) * 2001-05-31 2003-05-22 Solis Rosa Maria Encapsulation of nanosuspensions in liposomes and microspheres
PT1534313E (pt) 2002-07-30 2013-01-25 Omeros Corp Soluções e método de irrigação oftalmológica
DE10260313A1 (de) * 2002-12-20 2004-07-15 Siemens Ag Elektrische Maschine mit Wicklungen aus Litze
US20050176823A1 (en) * 2004-02-10 2005-08-11 Diaz Robert L. Intra-operative procedure for post-operative pain control
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI809304B (zh) 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
GB2627096A (en) 2021-10-14 2024-08-14 Pacira Pharmaceuticals Inc Bupivacaine multivesicular liposome formulations and uses thereof
CA3251322A1 (en) 2022-05-05 2023-11-09 Pfof Llc ANESTHETIC NERVE BLOCK AND PROCEDURE
US12070454B1 (en) 2022-05-05 2024-08-27 Pfof Llc Anesthetic nerve block and method
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251468B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12246092B1 (en) 2024-05-20 2025-03-11 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010277A1 (en) * 1993-10-13 1995-04-20 Chiroscience Limited Analgesic agent and its use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
AU704806B2 (en) * 1995-04-13 1999-05-06 Darwin Discovery Limited Levobupivacaine and its use as an anaesthetic in pregnant women

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010277A1 (en) * 1993-10-13 1995-04-20 Chiroscience Limited Analgesic agent and its use

Also Published As

Publication number Publication date
KR100516676B1 (ko) 2005-09-22
AU730390B2 (en) 2001-03-08
HU225151B1 (en) 2006-07-28
ES2199423T3 (es) 2004-02-16
PT981347E (pt) 2003-09-30
CA2279497A1 (en) 1998-09-11
HK1022651A1 (en) 2000-08-18
JP2001513812A (ja) 2001-09-04
CA2279497C (en) 2009-01-20
GB9704352D0 (en) 1997-04-23
WO1998038996A1 (en) 1998-09-11
NO994257L (no) 1999-11-02
PL190900B1 (pl) 2006-02-28
DK0981347T3 (da) 2003-09-15
KR20000075896A (ko) 2000-12-26
CN1249684A (zh) 2000-04-05
EP0981347A1 (en) 2000-03-01
EP0981347B1 (en) 2003-05-21
DE69814851T2 (de) 2004-01-22
NO322446B1 (no) 2006-10-09
ZA981779B (en) 1999-03-03
ATE240730T1 (de) 2003-06-15
AU6630498A (en) 1998-09-22
US5919804A (en) 1999-07-06
PL335561A1 (en) 2000-05-08
DE69814851D1 (de) 2003-06-26
BR9808303A (pt) 2000-05-16
HUP0000873A3 (en) 2002-10-28
IL131084A0 (en) 2001-01-28
HUP0000873A2 (hu) 2000-09-28
NO994257D0 (no) 1999-09-02

Similar Documents

Publication Publication Date Title
CN1089585C (zh) 左布比卡因在面部手术中的用途
US6417201B1 (en) Levobupivacaine as an analgesic agent
EP0727210B1 (en) Analgesic agent and its use
KR100535554B1 (ko) 소아과 수술에서의 레보부피바카인의 용도
AU8452898A (en) Levobupivacaine and its use
CN1128620C (zh) 左布比卡因在制备治疗偏头痛的药物中的用途
CN1145483C (zh) 左旋丁哌卡因和它作为一个麻醉剂在孕妇中的作用
HU214629B (hu) Eljárás műtét utáni hányinger és hányás kezelésére szolgáló gyógyszerkészítmény előállítására
WO1998038997A1 (en) Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
HK1022651B (en) The use of levobupivacaine in facial surgery
MXPA99008055A (es) Uso de levobupivacaina en cirugia facial
Phero et al. Local Anesthesia
Paul et al. Efficacy of Tramadol Hydrochloride with added Adrenaline and Tramadol Hydrochloride without Adrenaline as local anesthetic
CA2173207C (en) Levobupivacaine and its use as an anaesthetic in patients having or disposed to depressed myocardial contractility
Ghobrial Use of Diphenhydramine as an alternative to local anesthetics for patients with a known drug allergy
HU210322B (en) Process for production of preparations containing ropivacaine for treatment of iontophoresis
Khandagale et al. A REVIEW ON LOCAL ANESTHETIC SUSTAINED-RELEASE PAIN MANAGEMENT
KR19980703816A (ko) 레보부피바카인 및 임산부의 마취제로서 그것의 용도
MXPA99008056A (en) The use of levobupivacaine or ropivacaine in treating migraine

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
PB01 Publication
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20020828